Innovative Preclinical Assessment Tools for Safety and Efficacy of Protein and Peptide Therapeutics … Of Peptides and P-ANDAS A Case Study of Taspoglutide by Annie De Groot | Sep 9, 2019 | 0 comments EpiVax_PANDA_Taspoglutide_April_19_Final Submit a Comment Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website
